HyGel™ is a high concentration (2.5%) hyaluronic acid (HA)-based gel. Ionic Polymer Matrix (IPM) technology provides sustained delivery of HA.
HyGel™ is indicated for management of exudating wounds such as leg ulcers, pressure ulcers, diabetic ulcers, surgical wounds (post-operative and donor sites), mechanically or surgically debrided wounds, and for second-degree burns.
HyGel™ is indicated for the management and relief of burning, itching, and pain associated with various types of dermatoses; including atopic dermatitis, allergic contact dermatitis and radio-dermatitis.
|Antimicrobial format available|
|Compatible w/ topicals|
|Conforms readily to wound||●|
|Limited shelf life|
|Moisture vapor permeable|
|Preserved multiple dose|
|Secondary dressing required||●|
|Unpreserved unit dose|
|Usable on infected wounds|
Dry Skin Conditions
Moderate/Highly Exudating Wounds
Gentex Pharma is a privately held, specialty pharmaceutical company focusing on the development, marketing, and distribution of niche pharmaceuticals.